Evidence map›Paper›PMID 32328252›Full record

ArticleFood science & nutrition2020

Optimized production and safety evaluation of hispidin-enriched

I-Chen Li, Chang Cheng Chen, Sen-Je Sheu, I-Hsuan Huang, Chin-Chu Chen

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Foods (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells.International journal of molecular sciences · 2024
    Article
  7. Research Progress of Bioactive Components inMolecules (Basel, Switzerland) · 2024
    Review
  8. Comparative genomic analysis of Sanghuangporus sanghuang with other Hymenochaetaceae species.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Styrylpyrones fromAntioxidants (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Therapeutic Potential of Hispidin-Fungal and Plant Polyketide.Journal of fungi (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Article
  18. Safety evaluation of aqueous extracts ofFood science & nutrition · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

I-Chen LiBiotech Research Institute Grape King Bio Ltd Taoyuan Taiwan.
Chang Cheng ChenBiotech Research Institute Grape King Bio Ltd Taoyuan Taiwan.
Sen-Je SheuBiotech Research Institute Grape King Bio Ltd Taoyuan Taiwan.
I-Hsuan HuangDepartment of Food Science and Biotechnology Da-Yeh University Changhua Taiwan.
Chin-Chu ChenBiotech Research Institute Grape King Bio Ltd Taoyuan Taiwan.ORCID https://orcid.org/0000-0002-5340-6552
Shih Chien University · TWDayeh University · TWGrape King (Taiwan) · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hispidinPhellinus linteussafety assessmentSanghuangporus sanghuangtoxicity

Identifiers

PMID32328252
PMCPMC7174198
OpenAlexW3009527892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.